Cybersecurity for the Life Sciences R&D Ecosystem

The rate of data generation is increasing exponentially in today’s technology driven world. This is especially true for R&D activities in the life sciences, where technologies like next generation sequencing (NGS) are creating terabytes of genomics data in a single run. Researchers in pharmaceutical and biotech companies typically work with massive repositories of research, clinical trial, and patient data to help identify and optimize potential new drug candidates, generating proprietary intellectual property (IP) in the process…

To read more, please complete and submit the form below.